SCHEMBL7710779

SCHEMBL7710779

Cc1cccc(CC(NC(=O)OC(C)(C)C)c2ccc3c(c2)NC(=O)C(C)O3)c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.40
PARP1 P09874 2/20 0.38
IDO1 P14902 1/20 0.37
SMYD3 Q9H7B4 3/20 0.36
USP2 O75604 1/20 0.36
GAA P10253 1/20 0.36
KDR P35968 1/20 0.36
ALDH1A1 P00352 4/20 0.36
HPGD P15428 3/20 0.36
XBP1 P17861 3/20 0.36
HTT P42858 3/20 0.36
NPSR1 Q6W5P4 3/20 0.36
JAK2 O60674 2/20 0.36
S1PR4 O95977 2/20 0.36
LMNA P02545 2/20 0.36
HSP90AA1 P07900 1/20 0.36
THRB P10828 1/20 0.36
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7091085 0.91 NPSR1 (0.35) TP53IDO1GAAALDH1A1HPGD
SCHEMBL7708086 0.87 CTSS (0.43) PARP1IDO1SMYD3ALDH1A1KDM4E
SCHEMBL7708055 0.87 PARP1 (0.41) PARP1IDO1SMYD3KDRALDH1A1
SCHEMBL7713374 0.85 PARP1 (0.50) TP53PARP1IDO1ALDH1A1HPGD
SCHEMBL7713294 0.84 PARP1 (0.42) TP53PARP1IDO1SMYD3USP2
SCHEMBL7711091 0.83 PARP1 (0.42) PARP1IDO1SMYD3ALDH1A1KMT2A
SCHEMBL7713251 0.83 CTSS (0.45) TP53PARP1IDO1SMYD3ALDH1A1
SCHEMBL7708210 0.83 MC4R (0.41) TP53PARP1IDO1SMYD3KDR
SCHEMBL7711137 0.83 CTSL (0.45) TP53PARP1IDO1SMYD3KDR
SCHEMBL7708144 0.82 PARP1 (0.42) TP53PARP1IDO1SMYD3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed